Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young maintains a Hold rating on Staar Surgical (STAA) and lowers the price target from $46 to $43.
May 08, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity maintains a Hold rating on Staar Surgical and lowers the price target from $46 to $43.
The reduction in price target by Canaccord Genuity suggests a less optimistic outlook on Staar Surgical's stock price in the short term, potentially leading to negative investor sentiment and a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100